Privia Health: Operating Leverage and Growth Could Fuel a Re-rating
Privia Health (PRVA) has been compounding top-line growth while beginning to show meaningful EBITDA and free cash flow leverage. With a $2.87B market cap, low/no net debt, and improving operating metrics, the stock looks set up for a mid-term swing trade. Entry $22.50, target $27.50, stop $20.50.